IRIDEX Corporation (IRIX) has experienced challenges in growth. The company operates in the Healthcare sector, specifically in the Medical Devices industry.
Over the past 4 years, IRIDEX Corporation has achieved a revenue compound annual growth rate (CAGR) of 7.6%, while earnings have grown at 8.9% CAGR.
Historical revenue and profitability trends for IRIDEX Corporation
The chart above illustrates IRIDEX Corporation's revenue trajectory over the past 4 years. The revenue pattern shows the challenges the company has faced in recent periods.
Annual percentage change in revenue and earnings
Growth rates provide insight into the momentum of IRIDEX Corporation's business.
How efficiently IRIDEX Corporation converts revenue into profit
Profit margins reveal how much of each dollar of revenue IRIDEX Corporation retains at different stages:
Analyst estimates and forward-looking indicators
Wall Street analysts project IRIDEX Corporation to continue growing earnings in the coming year.
Based on our comprehensive analysis, IRIDEX Corporation (IRIX) demonstrates declining growth characteristics.
This growth analysis provides a comprehensive view of IRIDEX Corporation's historical performance and future outlook. Investors should consider these growth metrics alongside valuation, competitive positioning, and broader market conditions when making investment decisions. Past performance does not guarantee future results.
See how IRIDEX Corporation stacks up against similar companies
Explore growth analysis for top stocks
Related: IRIX Valuation, IRIX Dividend, IRIX Financial Health
Compare: IRIX vs AAPL, IRIX vs MSFT, IRIX vs GOOGL